Acworth Pharmaceuticals, Inc. Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Acworth Pharmaceuticals is a Cambridge, Massachusetts-based biotechnology research company focusing on oncology. It develops first-of-its-kind regulatory therapeutic candidates intended to kill cancer by restoring normal cellular function, achieved by creating mimetics of the intracellular regulatory protein DKK-3b. The approach targets cancer by reestablishing cellular regulation rather than directly attacking tumors. This places the company within the biotechnology research ecosystem, pursuing novel cancer therapies through a cellular-regulatory lens. The organization operates with a small team and is positioned in the U.S. biotech landscape. Its work centers on oncology and intracellular regulation, representing a specialized early-stage effort in the biotechnology sector.